exeter heart limited Company Information
Company Number
09376740
Next Accounts
Oct 2025
Shareholders
exeter heart holdings limited
Group Structure
View All
Industry
Specialist medical practice activities
Registered Address
7 sandy court, ashleigh way, langage business p, plymouth, devon, PL7 5JX
Website
https://www.exeterheart.comexeter heart limited Estimated Valuation
Pomanda estimates the enterprise value of EXETER HEART LIMITED at £300.2k based on a Turnover of £589.5k and 0.51x industry multiple (adjusted for size and gross margin).
exeter heart limited Estimated Valuation
Pomanda estimates the enterprise value of EXETER HEART LIMITED at £0 based on an EBITDA of £-8.2k and a 3.48x industry multiple (adjusted for size and gross margin).
exeter heart limited Estimated Valuation
Pomanda estimates the enterprise value of EXETER HEART LIMITED at £265k based on Net Assets of £118.2k and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Exeter Heart Limited Overview
Exeter Heart Limited is a live company located in plymouth, PL7 5JX with a Companies House number of 09376740. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in January 2015, it's largest shareholder is exeter heart holdings limited with a 100% stake. Exeter Heart Limited is a established, small sized company, Pomanda has estimated its turnover at £589.5k with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Exeter Heart Limited Health Check
Pomanda's financial health check has awarded Exeter Heart Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs


2 Strong

4 Regular

5 Weak

Size
annual sales of £589.5k, make it larger than the average company (£393.7k)
- Exeter Heart Limited
£393.7k - Industry AVG

Growth
3 year (CAGR) sales growth of 20%, show it is growing at a faster rate (8.2%)
- Exeter Heart Limited
8.2% - Industry AVG

Production
with a gross margin of 54%, this company has a comparable cost of product (54%)
- Exeter Heart Limited
54% - Industry AVG

Profitability
an operating margin of -3.9% make it less profitable than the average company (14%)
- Exeter Heart Limited
14% - Industry AVG

Employees
with 7 employees, this is similar to the industry average (7)
7 - Exeter Heart Limited
7 - Industry AVG

Pay Structure
on an average salary of £30.9k, the company has an equivalent pay structure (£30.9k)
- Exeter Heart Limited
£30.9k - Industry AVG

Efficiency
resulting in sales per employee of £84.2k, this is equally as efficient (£76.6k)
- Exeter Heart Limited
£76.6k - Industry AVG

Debtor Days
it gets paid by customers after 50 days, this is later than average (36 days)
- Exeter Heart Limited
36 days - Industry AVG

Creditor Days
its suppliers are paid after 25 days, this is quicker than average (37 days)
- Exeter Heart Limited
37 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Exeter Heart Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 38 weeks, this is less cash available to meet short term requirements (74 weeks)
38 weeks - Exeter Heart Limited
74 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 70.8%, this is a higher level of debt than the average (33.6%)
70.8% - Exeter Heart Limited
33.6% - Industry AVG
EXETER HEART LIMITED financials

Exeter Heart Limited's latest turnover from January 2024 is estimated at £589.5 thousand and the company has net assets of £118.2 thousand. According to their latest financial statements, Exeter Heart Limited has 7 employees and maintains cash reserves of £205.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||
Other Income Or Grants | |||||||||
Cost Of Sales | |||||||||
Gross Profit | |||||||||
Admin Expenses | |||||||||
Operating Profit | |||||||||
Interest Payable | |||||||||
Interest Receivable | |||||||||
Pre-Tax Profit | |||||||||
Tax | |||||||||
Profit After Tax | |||||||||
Dividends Paid | |||||||||
Retained Profit | |||||||||
Employee Costs | |||||||||
Number Of Employees | 7 | 5 | 4 | 5 | 5 | 4 | |||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | |
---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 45,198 | 59,249 | 17,199 | 14,532 | 12,412 | 16,549 | 22,066 | 29,421 | 34,073 |
Intangible Assets | 13,546 | 27,093 | 40,640 | 54,187 | |||||
Investments & Other | 25,000 | 25,000 | |||||||
Debtors (Due After 1 year) | |||||||||
Total Fixed Assets | 70,198 | 84,249 | 17,199 | 14,532 | 12,412 | 30,095 | 49,159 | 70,061 | 88,260 |
Stock & work in progress | |||||||||
Trade Debtors | 81,707 | 75,521 | 49,686 | 45,519 | 228,442 | 44,839 | 17,264 | 128,570 | 142,342 |
Group Debtors | 6,672 | ||||||||
Misc Debtors | 41,176 | 44,247 | 23,071 | 2,400 | |||||
Cash | 205,055 | 107,526 | 147,225 | 145,135 | 281,270 | 264,401 | 82,990 | 146,440 | 101,087 |
misc current assets | |||||||||
total current assets | 334,610 | 227,294 | 219,982 | 193,054 | 509,712 | 309,240 | 100,254 | 275,010 | 243,429 |
total assets | 404,808 | 311,543 | 237,181 | 207,586 | 522,124 | 339,335 | 149,413 | 345,071 | 331,689 |
Bank overdraft | |||||||||
Bank loan | |||||||||
Trade Creditors | 19,217 | 9,472 | 3,865 | 5,941 | 181,686 | 180,386 | 83,400 | 93,979 | 102,458 |
Group/Directors Accounts | 21,329 | 1,975 | 166 | 862 | |||||
other short term finances | |||||||||
hp & lease commitments | |||||||||
other current liabilities | 234,932 | 152,049 | 111,349 | 74,249 | |||||
total current liabilities | 275,478 | 163,496 | 115,380 | 81,052 | 181,686 | 180,386 | 83,400 | 93,979 | 102,458 |
loans | |||||||||
hp & lease commitments | |||||||||
Accruals and Deferred Income | |||||||||
other liabilities | |||||||||
provisions | 11,100 | 14,800 | 4,300 | 3,000 | 300 | 2,813 | 4,228 | 5,884 | 7,000 |
total long term liabilities | 11,100 | 14,800 | 4,300 | 3,000 | 300 | 2,813 | 4,228 | 5,884 | 7,000 |
total liabilities | 286,578 | 178,296 | 119,680 | 84,052 | 181,986 | 183,199 | 87,628 | 99,863 | 109,458 |
net assets | 118,230 | 133,247 | 117,501 | 123,534 | 340,138 | 156,136 | 61,785 | 245,208 | 222,231 |
total shareholders funds | 118,230 | 133,247 | 117,501 | 123,534 | 340,138 | 156,136 | 61,785 | 245,208 | 222,231 |
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | |
---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||
Operating Profit | |||||||||
Depreciation | 15,065 | 19,750 | 5,733 | 4,844 | 4,137 | 5,517 | 7,355 | 9,806 | 12,656 |
Amortisation | 13,546 | 13,547 | 13,547 | 13,547 | 13,547 | ||||
Tax | |||||||||
Stock | |||||||||
Debtors | 9,787 | 47,011 | 24,838 | -180,523 | 183,603 | 27,575 | -111,306 | -13,772 | 142,342 |
Creditors | 9,745 | 5,607 | -2,076 | -175,745 | 1,300 | 96,986 | -10,579 | -8,479 | 102,458 |
Accruals and Deferred Income | 82,883 | 40,700 | 37,100 | 74,249 | |||||
Deferred Taxes & Provisions | -3,700 | 10,500 | 1,300 | 2,700 | -2,513 | -1,415 | -1,656 | -1,116 | 7,000 |
Cash flow from operations | |||||||||
Investing Activities | |||||||||
capital expenditure | |||||||||
Change in Investments | 25,000 | ||||||||
cash flow from investments | |||||||||
Financing Activities | |||||||||
Bank loans | |||||||||
Group/Directors Accounts | 19,354 | 1,809 | -696 | 862 | |||||
Other Short Term Loans | |||||||||
Long term loans | |||||||||
Hire Purchase and Lease Commitments | |||||||||
other long term liabilities | |||||||||
share issue | |||||||||
interest | |||||||||
cash flow from financing | |||||||||
cash and cash equivalents | |||||||||
cash | 97,529 | -39,699 | 2,090 | -136,135 | 16,869 | 181,411 | -63,450 | 45,353 | 101,087 |
overdraft | |||||||||
change in cash | 97,529 | -39,699 | 2,090 | -136,135 | 16,869 | 181,411 | -63,450 | 45,353 | 101,087 |
exeter heart limited Credit Report and Business Information
Exeter Heart Limited Competitor Analysis

Perform a competitor analysis for exeter heart limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in PL7 area or any other competitors across 12 key performance metrics.
exeter heart limited Ownership
EXETER HEART LIMITED group structure
Exeter Heart Limited has no subsidiary companies.
exeter heart limited directors
Exeter Heart Limited currently has 4 directors. The longest serving directors include Sir Malcolm Dalrymple-Hay (Jan 2015) and Prof Nicholas Bellenger (Jan 2015).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Sir Malcolm Dalrymple-Hay | United Kingdom | 59 years | Jan 2015 | - | Director |
Prof Nicholas Bellenger | England | 54 years | Jan 2015 | - | Director |
Dr Matthew Lovell | United Kingdom | 51 years | Jan 2015 | - | Director |
Dr Andrew Ludman | United Kingdom | 47 years | Feb 2023 | - | Director |
P&L
January 2024turnover
589.5k
+11%
operating profit
-23.2k
0%
gross margin
54%
-6.65%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
118.2k
-0.11%
total assets
404.8k
+0.3%
cash
205.1k
+0.91%
net assets
Total assets minus all liabilities
exeter heart limited company details
company number
09376740
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
January 2015
age
10
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
January 2024
previous names
eh surgery limited (February 2015)
accountant
MARK HOLT & CO LIMITED
auditor
-
address
7 sandy court, ashleigh way, langage business p, plymouth, devon, PL7 5JX
Bank
-
Legal Advisor
-
exeter heart limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to exeter heart limited.
exeter heart limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EXETER HEART LIMITED. This can take several minutes, an email will notify you when this has completed.
exeter heart limited Companies House Filings - See Documents
date | description | view/download |
---|